Relevant bibliographies by topics / Clinical biochemistry

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Clinical biochemistry'

Author: Grafiati
Published: 4 June 2021
Last updated: 31 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Clinical biochemistry.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Clinical biochemistry"

1

Jovičić, Snežana, and Nada Majkić-Singh. "Medical Biochemistry as Subdiscipline of Laboratory Medicine in Serbia." Journal of Medical Biochemistry 36, no. 2 (April 1, 2017): 177–86. http://dx.doi.org/10.1515/jomb-2017-0010.

Full text
Abstract:
SummaryMedical biochemistry is the usual name for clinical biochemistry or clinical chemistry in Serbia, and medical biochemist is the official name for the clinical chemist (or clinical biochemist). This is the largest sub-discipline of the laboratory medicine in Serbia. It includes all aspects of clinical chemistry, and also laboratory hematology with coagulation, immunology, etc. Medical biochemistry laboratories in Serbia and medical biochemists as a profession are part of Health Care System and their activities are regulated through: the Health Care Law and rules issued by the Chamber of Medical Biochemists of Serbia. The first continuous and organized education for Medical Biochemists (Clinical Chemists) in Serbia dates from 1945, when the Department of Medical Biochemistry was established at the Pharmaceutical Faculty in Belgrade. In 1987 at the same Faculty a five years undergraduate study program was established, educating Medical Biochemists under a special program. Since the academic year 2006/2007 the new five year undergraduate (according to Bologna Declaration) and four-year postgraduate program according to EC4 European Syllabus for Postgraduate Training in Clinical Chemistry and Laboratory Medicine has been established. The Ministry of Education and Ministry of Public Health accredited these programs. There are four requirements for practicing medical biochemistry in the Health Care System: University Diploma of the Faculty of Pharmacy (Study of Medical Biochemistry), successful completion of the professional exam at the Ministry of Health after completion of one additional year of obligatory practical training in the medical biochemistry laboratories, membership in the Serbian Chamber of Medical Biochemists and licence for skilled work issued by the Serbian Chamber of Medical Biochemists. In order to present laboratory medical biochemistry practice in Serbia this paper will be focused on the following: Serbian national legislation, healthcare services organization, sub-disciplines of laboratory medicine and medical biochemistry as the most significant, education in medical biochemistry, conditions for professional practice in medical biochemistry, continuous quality improvement, and accreditation. Serbian healthcare is based on fundamental principles of universal health coverage and solidarity between all citizens.
APA, Harvard, Vancouver, ISO, and other styles
2

Majkić-Singh, Nada. "Education and Recognition of Professional Qualifications in the Field of Medical Biochemistry in Serbia." Journal of Medical Biochemistry 30, no. 4 (October 1, 2011): 279–86. http://dx.doi.org/10.2478/v10011-011-0013-7.

Full text
Abstract:
Education and Recognition of Professional Qualifications in the Field of Medical Biochemistry in Serbia Medical biochemistry is the usual name for clinical biochemistry or clinical chemistry in Serbia, and medical biochemist is the official name for the clinical chemist (or clinical biochemist). This is the largest sub-discipline of the laboratory medicine in Serbia. It includes all aspects of clinical chemistry, and also laboratory hematology with coagulation, immunology, etc. Medical biochemistry laboratories in Serbia and medical biochemists as a profession are part of Health Care System and their activities are regulated through: the Health Care Law and rules issued by the Chamber of Medical Biochemists of Serbia. The first continuous and organized education for Medical Biochemists (Clinical Chemists) in Serbia dates from 1945, when the Department of Medical Biochemistry was established at the Pharmaceutical Faculty in Belgrade. In 1987 at the same Faculty a five years undergraduate branch was established, educating Medical Biochemists under a special program. Since school-year 2006/2007 the new five year undergraduate (according to Bologna Declaration) and postgraduate program of four-year specialization according to EC4 European Syllabus for Post-Gradate Training in Clinical Chemistry and Laboratory Medicine has been established. The Ministry of Education and Ministry of Public Health accredits the programs. There are four requirements for practicing medical biochemistry in the Health Care System: University Diploma of the Faculty of Pharmacy (Study of Medical Biochemistry), successful completion of the profession exam at the Ministry of Health after completion of one additional year of obligatory practical training in the medical biochemistry laboratories, membership in the Serbian Chamber of Medical Biochemists and licence for skilled work issued by the Serbian Chamber of Medical Biochemists. The process of recognition of a foreign higher education document for field of medical biochemistry is initiated on request by Candidate. The process of recognition of foreign higher education documents is performed by the University. In the process of recognition in Serbia national legislations are applied as well as international legal documents of varying legal importance.
APA, Harvard, Vancouver, ISO, and other styles
3

Majkic-Singh, Nada. "Society of medical biochemists of Serbia and Montenegro: 50 years anniversary." Jugoslovenska medicinska biohemija 24, no. 3 (2005): 157–70. http://dx.doi.org/10.2298/jmh0503157m.

Full text
Abstract:
Medical biochemistry (synonyms: clinical chemistry or clinical biochemistry) in the terms of professional and scientific discipline, stems from and/or has developed along with the natural sciences and its influences (mathematics, physics, chemistry and biochemistry) and medical sciences as well (physiology, genetics, cell biology). As a scientific discipline, medical biochemistry studies metabolic processes of physiological and pathological changes with humans and animals. Applying analytical chemistry's and biochemistry's techniques enables medical biochemists to gain plenty of information related to diagnosis and prognosis which serve physicians to asses the gravity of illness and prescribe healing therapy. Therefore medical biochemistry is an integral part of modern medicine. This discipline was dubbed various, often confusing names such as pathology, physiology, clinical biology, clinical pathology, chemical pathology, clinical biochemistry, medical biochemistry, clinical chemistry and laboratory medicine, all depending on place of origin. The official, internationally accepted name - clinical chemistry, was mentioned for the first time in 1912 by Johan Scherer, who described his laboratory as Clinical Chemistry Laboratory (Klinisch Chemische Laboratorium) in the hospital Julius in Wurzburg in Germany. After creating national societies of clinical chemists, Professor Earl J. King of Royal Postgraduate Medical School from London incited an initiative to unite national societies into the organization with worldwide character - it was the International Association of Clinical Biochemists, monitored by the International Union for Pure and Applied Chemistry (IUPAC). On 24 July 1952 in Paris, a Second International Congress of Biochemistry was held. A year later, in Stockholm, the name of a newly formed association was altered into International Federation of Clinical Chemistry, which was officially accepted in 1955 in Brussels. Today this federation-s name is International Federation for Clinical Chemistry and Laboratory Medicine (IFCC). Right after the World War II our medical biochemists began to gather within their expert societies. Even before 1950 Pharmaceutical Society of Serbia hosted laboratory experts among whom the most active were Prof. Dr. Aleksandar Damanski for bromatology, Prof. Dr. Momcilo Mokranjac for toxicology and Docent Dr. Pavle Trpinac for biochemistry. When the Managing Board of the Pharmaceutical Society of National Republic of Serbia held its session on 22 December 1950, an issue was raised with reference to creation of a Section that would gather together the laboratory experts. Section for Sanitary Chemistry, combining all three profiles of laboratory staff, i.e. medical biochemists, sanitary chemists and toxicologists, was founded on 1st of January 1951. On 15 May 1955, during the sixth plenum of the Society of Pharmaceutical Societies of Yugoslavia (SFRY) held in Split, the decision was passed to set up a Section for Medical Biochemistry in SFDJ. The Section for Medical Biochemistry in SFDJ was renamed into Society for Medical Biochemistry of SFDJ based on the decision passed during the 16th plenum of SFDJ, held on 15 May 1965 in Banja Luka. Pursuant to the decision passed by SMBY on 6 April 1995 and based on the historic data, 15 May was declared as being the official Day of the Society of Medical Biochemists of Yugoslavia. The purpose of YuSMB (currently SMBSCG) is to gather medical biochemists who would develop and enhance all the branches of medical biochemistry in health industry. Its tasks are as following: to standardize operations in clinical-biochemical laboratories, education of young biochemists on all levels, encouraging scientific research, setting up of working norms and implementation, execution and abiding by the ethics codices with health workers. SMBSCG is to promote the systemized standards in the field of medical biochemistry with the relevant federal and republican institutions. SMBSCG is to enable exchange of experiences of its members with the members of affiliate associations in the country and abroad. .
APA, Harvard, Vancouver, ISO, and other styles
4

Lloyd, G. "Clinical Biochemistry." British Journal of Biomedical Science 68, no. 1 (January 2011): 50–51. http://dx.doi.org/10.1080/09674845.2011.11978202.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bloom, Stephen. "Clinical biochemistry⇓." BMJ 328, no. 7445 (April 17, 2004): s153.2—s154. http://dx.doi.org/10.1136/bmj.328.7445.s153-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Whitby, L. "Clinical Biochemistry." Journal of Clinical Pathology 38, no. 5 (May 1, 1985): 600. http://dx.doi.org/10.1136/jcp.38.5.600-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Nexø, Ebba. "Clinical biochemistry." FEBS Letters 375, no. 3 (November 20, 1995): 312–13. http://dx.doi.org/10.1016/0014-5793(95)90102-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gondwe, ATD. "Pre-clinical and clinical biochemistry?" Biochemical Education 13, no. 1 (January 1985): 19–21. http://dx.doi.org/10.1016/0307-4412(85)90120-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hall, Elizabeth. "Clinical Biochemistry: Metabolic and Clinical Aspects." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 46, no. 1 (January 2009): 89. http://dx.doi.org/10.1258/acb.2008.200828.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vella, F. "Clinical biochemistry. Metabolic and clinical aspects." Biochemical Education 24, no. 4 (October 1996): 240. http://dx.doi.org/10.1016/s0307-4412(97)80781-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Clinical biochemistry"

1

McCoy, Maurice Anthony. "Hypomagnesaemia in ruminants : incidence, clinical biochemistry and control." Thesis, Queen's University Belfast, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.300617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ricketts, David John. "Reconfiguration and modernisation of a district general hospital clinical biochemistry service." Thesis, University of Portsmouth, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.516885.

Full text
Abstract:
Context: The clinical biochemistry department at the North Middlesex University Hospital successfully won funding under the pathology modernisation initiative to automate the core laboratory in 2000. Following procurement procedures, the contract was awarded to two vendors who offered an 'islands of automation' solution as opposed to the popular fully tracked solution. The automation was installed with minor process change, but process reviews occurring in 2003 with the advent of Lean Six Sigma. Methods: The Executive War College meeting in 2003 introduced new quality management tools Lean, Six Sigma and activity-based costing, to the pathology environment. These methods were incorporated into the clinical biochemistry department and the impact of these was studied over a five year period to assess if any additional benefit could be offered when compared to the implementation of automation on its own. The later being introduced using traditional process management methodology. The process review expanded to include the specimen reception area, as delays at this point had a major impact on the performance of the automated laboratory. Results: Introduction of process management tools improved turn around time for key indicators by as much as 50%, compared to automation alone, whilst removing the variation in time to result due to the pull system of samples setting a defined time for samples to arrive for analysis. The total laboratory space for clinical biochemistry was reduced by 32% allowing for the formation of a molecular laboratory and increasing the sample reception area by 133%. The avoided build cost to extend the department for these works was £265,500 .. The value added activity post process change was scored at 17.21 % which was an international best for laboratories who had been assessed using this tool. Using benchmarking data, £1,350,000 of avoided costs, in the year 2007-8, were calculated as a result of the changes made to the service. A staff survey of the changes supported the change process with positive feedback. Automation of request forms using electronic ordering show a dramatic improvement on quality compared to the hand written forms, which had a Sigma level of between 2 and 3, improving to 4.1 Sigma when the electronic requesting went live. ii Conclusion: All process tools strongly recommend taking a baseline reading of the data before making any change, this recommendation was verified as a must in this study. The advent of automation proved very popular with the staff as it removed repetitive functions and made some manual processes obsolete, thus improving morale. The impact of automation however did not improve significantly the turnaround times, but enabled sample archiving and retrieval to be less prone to error. The study found that by aligning the work processes in specimen reception to those processes in the clinical biochemistry department, this created the major benefit. Therefore a strong recommendation is that process managing of specimen reception areas is a must before undertaking any purchase of automated systems. Any delay in the laboratory is minor compared to the potential for delay that poor process can give in the pre-analytical phase. Benchmarking allowed a year on year comparison to be made, but the study highlighted the need to drill into the data and understand the service change when looking at cost per unit. This allowed the return on investment for the new technology to be assessed, in this study the return was realised in eighteen months. Benchmarking highlighted that the quality improvement that new assays provided to patient care impacted marginally on the test volumes but had a 15% impact on the non-pay budget. The use of activity-based costing compliments both Lean and Six Sigma by allowing the true cost of the work to be assessed with both value adding activity and avoided cost, the money not spent as opposed to direct cost cuts, to be calculated. The activitybased costing allowed staff to focus their jobs onto those tasks which were appropriate to their grade and identify and reduce those tasks which were not, improving job satisfaction and morale. Avoiding cost through good process change has a positive impact on both the patient and the budget, which cannot be achieved by cost improvement programmes based on a percentage change in the money allocated to the department.
APA, Harvard, Vancouver, ISO, and other styles
3

Baral, Randolph Matias. "Feline clinical biochemistry: new paradigms for interpreting results and comparing analysers." Thesis, The University of Sydney, 2015. http://hdl.handle.net/2123/13616.

Full text
Abstract:
The overall aim of this project was to provide an evidence-based means for comparison of feline biochemical analytes to increase the ability to distinguish between sickness and health of cats and enhance veterinarians’ clinical decision-making. Chapter 1, the literature review, has two sections; the first outlines how traditional, population-based reference intervals are generated, followed by a description of subject-based reference limits that are being implemented in human clinical pathology. The second section describes the current approaches for method comparison of analyte values obtained from clinical pathology analysers. Since in-house biochemistry analysers are unable to be calibrated by end-users (such as veterinary hospital staff), any inherent bias in the determination of analyte values cannot be corrected (as it can for commercial laboratory analysers). Bias of in-house biochemistry equipment is well recognised, and Chapter 2 provides the first concurrent assessment of multiple analysers, using a grading system that was devised to assess constant bias and degree of proportional bias. It conclusively demonstrates that results from in-house analysers should not be directly compared to results from others, nor to those determined by commercial laboratory analysers. A potential solution may lie in the ability of correctly generated reference intervals to account for these analysers’ inherent bias. Chapter 3 demonstrates that reference intervals provided by in-house biochemistry analyser manufacturers as well as a commercial laboratory do not appear to account for the biases for all analytes and consequently may be inaccurate for local hospital population feline populations. It is now recognised in human clinical pathology, that for many biochemical analytes, traditional population-based reference intervals have limitations, as a significant change in an individual’s analyte concentration within the reference limits may still be an important medical indicator for that individual. Conversely, values outside these limits are not always clinically important for an individual. For appropriate analytes, subject-based reference values, often called ‘reference change values’ are used; these are determined from biological variation data which reflect the inherent physiological variation of these analytes within and between individuals. Chapter 4 defines the biological variation of clinical biochemical analytes in cats, determining which analytes are suited for traditional reference interval interpretation or would be better interpreted with reference change values. The high individuality found for most analytes indicate that subject-based reference values (which are determined and documented) should be used to assess feline plasma biochemistry samples. The generation of biological variation data enabled assessment of precision (repeatability) of in-house analysers in relation to this data, the recognised technique for human clinical pathology. These results are documented in Chapter 5 which found that the precision of results from these in-house and commercial laboratory analysers were generally acceptable, so large differences between repeated results from the same patient are more likely to be due to biological changes rather than analyser variation. Chapter 6 assesses the total error (based on a combination of bias and precision) of values from three in-house biochemistry analysers in relation to a commercial laboratory analyser for feline plasma using multiple quality specifications. This study required an adaptation of method comparison techniques used for human clinical pathology so that these techniques could be used with equipment that is unable to be calibrated. This chapter concludes that in-house analysers provide acceptable results and few clinical decisions would be different based on the results determined by three in-house analysers compared to those determined by the commercial laboratory. The last chapter is a discussion on the impact this research will have on veterinary practice, the projects’ limitations and future directions for this avenue of research.
APA, Harvard, Vancouver, ISO, and other styles
4

Jones, R. M. L. "Studies of proteolytic fragments of clinical interest." Thesis, University of Oxford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.354831.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Leslie, Carolyn Elizabeth. "Studies on clinical isolates of Aspergillus Fumigatus." Thesis, Heriot-Watt University, 1985. http://hdl.handle.net/10399/1653.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

McLellan, Antony Christopher. "The glyoxalase system in clinical diabetes mellitus." Thesis, University of Essex, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.333336.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rowan, Andrew D. "The pineapple proteinases : characterization and clinical use." Thesis, Open University, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.290495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

John, W. G. "Glycated proteins : Their measurement and clinical applications." Thesis, De Montfort University, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.376968.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Smellie, W. Stuart A. "Clinical applications of an assay for intact proinsulin." Thesis, University of Oxford, 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.308805.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

O'Harte, Finbarr Paul Mary. "Clinical biochemistry of cobalt deficiency in sheep with particular reference to methylmalonic acid." Thesis, Queen's University Belfast, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Clinical biochemistry"

1

Laboratory, Corvallis Environmental Research, ed. Clinical biochemistry. Corvallis, Or., USA: US Environmental Protection Agency, Environmental Research Laboratory, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Titov, Vladimir. Clinical biochemistry: lectures. ru: INFRA-M Academic Publishing LLC., 2017. http://dx.doi.org/10.12737/24551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sorenson, Dean K. Clinical biochemistry synopsis. Salt Lake City: University of Utah Press, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

L, Williams David, and Marks Vincent, eds. Biochemistry in clinical practice. New York: Elsevier, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Marshall, William J., Ph. D. and Bangert S. K, eds. Clinical biochemistry: Metabolic and clinical aspects. New York: Churchill Livingstone, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marshall, William J., Ph. D. and Bangert S. K, eds. Clinical biochemistry: Metabolic and clinical aspects. Edinburgh: Churchill Livingstone/Elsevier, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rao, N. Mallikarjuna. Medical biochemistry. 2nd ed. New Delhi: New Age International (P) Ltd., Publishers, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Martin, Crook, ed. Notes on clinical biochemistry. Singapore: World Scientific, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

H, Gowenlock Alan, McMurray Janet R, McLauchlan Donald M, and Varley Harold, eds. Varley's practical clinical biochemistry. 6th ed. Boca Raton, Fla: CRC Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Varley, Harold. Varley's Practical clinical biochemistry. 6th ed. London: Heinemann Medical, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Clinical biochemistry"

1

Ashby, Helen. "Clinical biochemistry." In Instant Wisdom for GPs, 37–43. 2nd ed. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003304586-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Surugiu, Roxana, Daiana Burdusel, Mihai-Andrei Ruscu, Andreea Cercel, Dirk M. Hermann, Israel Fernandez Cadenas, and Aurel Popa-Wagner. "Clinical Ageing." In Subcellular Biochemistry, 437–58. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-26576-1_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ciaccio, Marcello, Luisa Agnello, and Anna Maria Ciaccio. "Liver: From Biochemistry to Clinical Biochemistry." In Clinical and Laboratory Medicine Textbook, 95–123. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-24958-7_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bateson, Malcolm C., and Ian A. D. Bouchier. "Liver biochemistry." In Clinical Investigations in Gastroenterology, 153–78. Dordrecht: Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-011-5630-1_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bateson, Malcolm C., and Ian A. D. Bouchier. "Liver Biochemistry." In Clinical Investigations in Gastroenterology, 139–61. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-53786-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bateson, M. C., and I. A. Bouchier. "Liver biochemistry." In Clinical Investigations in Gastroenterology, 157–82. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-2633-2_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Devi, Rooma, Aman Chauhan, Simmi Kharb, and Chandra Shekhar Pundir. "Colorimetry." In Clinical Biochemistry, 175–80. New York: Jenny Stanford Publishing, 2023. http://dx.doi.org/10.1201/9781003455660-14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Devi, Rooma, Aman Chauhan, Simmi Kharb, and Chandra Shekhar Pundir. "Specimen Collection and Processing." In Clinical Biochemistry, 17–23. New York: Jenny Stanford Publishing, 2023. http://dx.doi.org/10.1201/9781003455660-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Devi, Rooma, Aman Chauhan, Simmi Kharb, and Chandra Shekhar Pundir. "Proteins." In Clinical Biochemistry, 91–112. New York: Jenny Stanford Publishing, 2023. http://dx.doi.org/10.1201/9781003455660-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Devi, Rooma, Aman Chauhan, Simmi Kharb, and Chandra Shekhar Pundir. "Oxalic Acid." In Clinical Biochemistry, 287–90. New York: Jenny Stanford Publishing, 2023. http://dx.doi.org/10.1201/9781003455660-29.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Clinical biochemistry"

1

Gorlov, D., Nikolai Jujukin, I. Kuznetsov, and E. Litvinov. "PROSPECTS FOR USING THE ANALYTICAL CAPABILITIES OF CLINICAL CHEMISTRY IN SPORTS BIOCHEMISTRY." In SCIENCE AND INNOVATION IN THE MODERN WORLD. FSBE Institution of Higher Education Voronezh State University of Forestry and Technologies named after G.F. Morozov, 2024. http://dx.doi.org/10.58168/simw2024_59-66.

Full text
Abstract:
The topic related to the use of the analytical capabilities of clinical chemistry in sports biochemistry is quite relevant, in that thanks to it, training has been optimized, and research has also helped improve monitoring of the health of athletes, which is very important in our time. This scientific article is devoted to the study of the physical and chemical principles of the analysis of human biological fluids, which can significantly expand the methodological arsenal of sports biochemistry and sports pharmacology. The work contains a review of the literature of sports biochemistry and clinical biochemistry, examples, as well as new opportunities in the study of organ proteins and muscle tissue proteins. Study results show optimization of training, diagnosis of athletes' condition and prevention of health problems.
APA, Harvard, Vancouver, ISO, and other styles
2

Dikal, M. V. "Implementation of innovative teaching methods during study clinical biochemistry." In INFORMATION TECHNOLOGIES AND MANAGEMENT IN HIGHER EDUCATION AND SCIENCES. PART 1. Baltija Publishing, 2022. http://dx.doi.org/10.30525/978-9934-26-277-7-71.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jin, Zhang, Wang Meng, Lin Na, and Du Hang. "Exploration and Reform in Education of Biochemistry for Clinical Medicine." In 2021 10th International Conference on Applied Science, Engineering and Technology (ICASET 2021). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/aer.k.210817.025.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jiang, Rui, Ziyan Zhang, Han Wu, and Chao Zhang. "Research Progress of Bone Tumor Clinical Diagnosis." In 2018 International Workshop on Bioinformatics, Biochemistry, Biomedical Sciences (BBBS 2018). Paris, France: Atlantis Press, 2018. http://dx.doi.org/10.2991/bbbs-18.2018.21.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chakrabarty, Krishnendu. "Digital Microfluidics: Connecting Biochemistry to Electronic System Design." In ASME 2007 5th International Conference on Nanochannels, Microchannels, and Minichannels. ASMEDC, 2007. http://dx.doi.org/10.1115/icnmm2007-30158.

Full text
Abstract:
Microfluidics-based biochips are revolutionizing high-throughput sequencing, parallel immunoassays, blood chemistry for clinical diagnostics, DNA sequencing, and environmental sensing. The complexity of microfluidic devices, also referred to as lab-on-a-chip, is expected to become significant in the near future due to the need for multiple and concurrent biochemical assays on multifunctional and reconfigurable platforms. This paper provides an overview of droplet-based “digital” microfluidic biochips. It presents early work on top-down system-level computer-aided design (CAD) tools for the synthesis, testing and reconfiguration of microfluidic biochips. These CAD techniques allow the biochip to concentrate on the development of the nano- and micro-scale bioassays, leaving assay optimization and implementation details to design automation tools.
APA, Harvard, Vancouver, ISO, and other styles
6

Long, Kaihua, Xiaojia Hu, Chunliu Wang, and Ye Li. "Clinical Effect of Xuefu Zhuyu Tang Combined with Atorvastatin on Hypertension Complicated with Coronary Heart Disease." In 2018 International Workshop on Bioinformatics, Biochemistry, Biomedical Sciences (BBBS 2018). Paris, France: Atlantis Press, 2018. http://dx.doi.org/10.2991/bbbs-18.2018.17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Metón, Isidoro, Joan Carles Rodríguez, and Rosa Giménez. "INTEGRATIVE LEARNING THROUGH TRANSVERSAL CLINICAL CASES IN THE SUBJECT OF CLINICAL BIOCHEMISTRY AND MOLECULAR PATHOLOGY OF THE PHARMACY DEGREE." In 14th International Technology, Education and Development Conference. IATED, 2020. http://dx.doi.org/10.21125/inted.2020.0293.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Кіндрат, Ірина. "CLINICAL CASE BASED LEARNING AS AN INNOVATIVE METHOD FOR TEACHING BIOCHEMISTRY IN MEDICAL UNIVERSITY." In LE TENDENZE E MODELLI DI SVILUPPO DELLA RICERСHE SCIENTIFICI. European Scientific Platform, 2020. http://dx.doi.org/10.36074/13.03.2020.v2.17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lebeña, Nuria, Arantza Casillas, and Alicia Pérez. "Temporal Name Entity Recognition and Relation Extraction in Clinical Electronic Health Records with Span-based Entity and Relation Transformer." In ICBBB 2024: 2024 14th International Conference on Bioscience, Biochemistry and Bioinformatics. New York, NY, USA: ACM, 2024. http://dx.doi.org/10.1145/3640900.3640901.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Rumyantsev, Yegor Y., Tatiana I. Okonenko, Kseniya Y. Kartysheva, Galina A. Antropova, and Svetlana V. Merbakh. "Biomarkers of clinical course in covid-19 patients with cardiovascular comorbidity." In Innovations in Medical Science and Education. Dela Press Publishing House, 2022. http://dx.doi.org/10.56199/dpcsms.vyxd9415.

Full text
Abstract:
A new coronavirus infection (COVID-19) tends to have severe course in patients with cardiovascular disease, with routine laboratory tests predicting adverse outcomes in such patients. The results of studies of interplaying factors are contradictory and require further investigation. The aim was to analyze the parameters of general blood analysis, inflammatory response, cholesterol and hemostasis in the groups of patients who underwent COVID-19-associated pneumonia with cardiovascular comorbidity. The study was conducted in Veliky Novgorod from December 2020 to April 2022 during inpatient treatment of patients diagnosed with COVID-19-associated novel coronavirus infection. We analyzed 108 case histories of patients. The patient’s data was divided into 2 groups. Group I consisted of 86 patients with cardiovascular diseases at the time of admission. The control group consisted of 22 patients without concomitant cardiovascular diseases. The data of general blood analysis, biochemistry and hemostasis were assessed on the day of admission and on the day of discharge. Results. Average bed-days of patients with cardiovascular pathology were longer than in the control group; in addition, there was a correlation of the duration of hospitalization and CRP level with the initial level of total cholesterol. Also, positive correlation of CRP level with blood fibrinogen content was found, which was more expressed in patients with cardiovascular comorbidity. Conclusions. The results of our study, in general, do not contradict the results accumulated in the world. Those findings should be compared with other studies and to monitor COVID-19 disease trends.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Clinical biochemistry' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography